Market revenue in 2023 | USD 17.2 million |
Market revenue in 2030 | USD 41.8 million |
Growth rate | 13.5% (CAGR from 2023 to 2030) |
Largest segment | Oligonucleotide synthesis |
Fastest growing segment | Gene Synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oligonucleotide Synthesis, Gene Synthesis |
Key market players worldwide | Thermo Fisher Scientific Inc, Twist Bioscience Corp, Codexis Inc, LGC Group, Eurofins Scientific SE, Genscript Biotech Corp Class H, Bioneer, IBA Lifesciences, Danaher Corp, Quintarabio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna synthesis market will help companies and investors design strategic landscapes.
Oligonucleotide synthesis was the largest segment with a revenue share of 55.81% in 2023. Horizon Databook has segmented the Saudi Arabia dna synthesis market based on oligonucleotide synthesis, gene synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia has been investing in biotechnology and life sciences initiatives, including R&D. The growth of these initiatives is expected to drive the demand for DNA synthesis in various applications, such as genomics, diagnostics, and therapeutics.
The government initiated Saudi Human Genome Program in 2018 to develop the field of diagnostics and prevent genetic diseases. In addition, extensive research studies involving sequencing can help expand the usage rate of advanced DNA sequencing techniques in this country.
According to the Centre for Arab Genomic Studies, Saudi Arabia has a high burden of genetic diseases, primarily due to consanguinity. The number of cancer cases and deaths has also increased in recent years in the country. As per the GLOBOCAN data, in 2020, around 27,885 new cancer cases were diagnosed in Saudi Arabia, and around 13,069 people succumbed to cancer.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia dna synthesis market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia dna synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account